Morgan Stanley Reinstates Overweight on CRH, Announces $139 Price Target
Morgan Stanley analyst Angel Castillo reinstates CRH (NYSE:CRH) with a Overweight and announces $139 price target.
Economy · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Morgan Stanley analyst Angel Castillo reinstates CRH (NYSE:CRH) with a Overweight and announces $139 price target.
Arcosa, Inc. (NYSE:ACA) ("Arcosa" or the "Company"), a provider of infrastructure-related products and solutions, today announced that the Company’s stockholders approved the acquisition by CRH
DA Davidson analyst Garik Shmois initiates coverage on CRH (NYSE:CRH) with a Buy rating and announces Price Target of $137.
Truist Securities analyst Rohit Seth maintains D.R. Horton (NYSE:DHI) with a Hold and lowers the price target from $150 to $140.
The investment portfolio of President Donald Trump and Berkshire Hathaway have 17 stocks in common. Here's a look at the list.